Latest Costamare Inc (CMRE) Headlines Costamare Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Costamare Inc (CMRE) Headlines

Costamare Inc. Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2013
Marketwire - Fri Feb 21, 7:44AM CST
Costamare Inc. (the "Company") (NYSE: CMRE) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2013 (the "Annual Report") has been filed with the U.S. Securities and Exchange Commission and can be accessed on the Company's website, www.costamare.com, in the "Investors" section under "Annual Reports".

Costamare Inc. Reports Results for the Fourth Quarter and Year Ended December 31, 2013
Marketwire - Mon Jan 27, 3:06PM CST
Costamare Inc. ("Costamare" or the "Company") (NYSE: CMRE) today reported unaudited financial results for the fourth quarter and the year ended December 31, 2013.

Costamare Inc. Sets the Date for Its Fourth Quarter 2013 Results Release, Conference Call and Webcast
Marketwire - Wed Jan 22, 9:01AM CST
Costamare Inc. (NYSE: CMRE) announced today that it will release its results for the fourth quarter and year ended December 31, 2013 after the market closes in New York on Monday, January 27, 2014. Following the earnings release, on the following day, Tuesday, January 28, 2014 at 8:30 a.m. ET, Costamare's management team will hold a conference call to discuss the financial results.

Costamare announces pricing of its 8.50% series C preferred stock
M2 - Tue Jan 14, 9:01AM CST
An owner and provider of container ships for charter, Greek company Costamare Inc (NYSE:CMRE) stated on Monday that it priced 4m shares of its 8.50% series C cumulative redeemable perpetual preferred stock at USD25.00 per share, par value USD0.0001 per share and a liquidation preference of USD25.00 per share.

Costamare Inc. Announces Pricing of its 8.50% Series C Preferred Stock
Business Wire - Mon Jan 13, 4:33PM CST
Costamare Inc. (the "Company") (NYSE:CMRE) announced today that its offering of 4,000,000 shares of its 8.50% Series C Cumulative Redeemable Perpetual Preferred Stock, par value $0.0001 per share, liquidation preference $25.00 per share (the "Series C Preferred Stock"), was priced at $25.00 per share. The gross proceeds from the offering before the underwriting discount and other offering expenses are expected to be $100,000,000. The Company has also granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of the Series C Preferred Stock. Dividends will be payable on the Series C Preferred Stock at a rate of 8.50% per annum of the stated liquidation preference. Following the offering, the Company intends to file an application to list the Series C Preferred Stock on the New York Stock Exchange.

Costamare Inc. Announces Public Offering of Series C Preferred Stock
Business Wire - Mon Jan 13, 8:21AM CST
Costamare Inc. (the "Company") (NYSE:CMRE) announced today that it plans to offer its Series C Cumulative Redeemable Perpetual Preferred Stock, par value $0.0001 per share, liquidation preference $25.00 per share (the "Series C Preferred Stock") to the public. In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase additional shares of the Series C Preferred Stock. Following the offering, the Company intends to file an application to list the Series C Preferred Stock on the New York Stock Exchange.

Costamare Inc. Declares Quarterly Common Stock Dividend of $0.27 per Share
Marketwire - Mon Jan 06, 3:05PM CST
Costamare Inc. (the "Company") (NYSE: CMRE) has declared a quarterly dividend on its common stock of $0.27 per share for the quarter ended December 31, 2013.

Costamare Inc. Declares Quarterly Dividend on Its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock
Marketwire - Thu Jan 02, 3:05PM CST
Costamare Inc. (the "Company") (NYSE: CMRE) has declared a cash dividend of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") (NYSE: CMRE PR B) for the period from October 15, 2013 to January 14, 2014. The dividend will be paid on January 15, 2014 to all Series B Preferred Stock holders of record as of January 14, 2014.

Costamare Inc.Corporate Event Announcement Notice
Wall Street Horizon - Thu Dec 19, 7:47PM CST
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR), today announced that scientists at the Institute have developed a new computer-based method to identify gene signatures that can serve as prognostic biomarkers for cancer. The researchers, Drs. Guanming Wu, Research Associate, and Lincoln Stein, Platform Leader and Principal Investigator, Informatics and Bio-computing Platform, used this technique to discover gene expression signatures related to survival in breast and ovarian cancers. Their study was published in the journal Genome Biology.

Costamare Inc. Announces Election of Class III Directors at 2013 Annual Meeting of Stockholders
Marketwire - Thu Oct 31, 3:09PM CDT
Costamare Inc. (the "Company") (NYSE: CMRE), an international owner and provider of containerships for charter, announced the election of two Class III directors at the Company's annual meeting of stockholders held in Athens today.

Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2013
Marketwire - Wed Oct 23, 3:15PM CDT
Costamare Inc. ("Costamare" or the "Company") (NYSE: CMRE) today reported unaudited financial results for the third quarter and nine months ended September 30, 2013.

Costamare Inc. Files Shelf Registration Statement
Marketwire - Mon Oct 21, 4:43PM CDT
Costamare Inc. (the "Company") (NYSE: CMRE) announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission (the "SEC"). The registration statement only covers new issuances by the Company. It is not available for sales by members of the Konstantakopoulos family, the principal stockholders of the Company, as they do not have any current intention to sell their shares.

Costamare Inc. Sets the Date for Its Third Quarter 2013 Results Release, Conference Call and Webcast
Marketwire - Fri Oct 18, 7:04AM CDT
Costamare Inc. (NYSE: CMRE) announced today that it will release its results for the third quarter and nine months ended September 30, 2013 after the market closes in New York on Wednesday, October 23, 2013. Following the earnings release, on the following day, Thursday, October 24, 2013 at 8:30 a.m. EDT, Costamare's management team will hold a conference call to discuss the financial results.

Costamare Keeps Dividend Steady
Rich Duprey, The Motley Fool - Motley Fool - Wed Oct 09, 10:53PM CDT
Containership owner  Costamare announced yesterday its third-quarter dividend of $0.27 per share, the same rate it's paid since 2011. The company has 74.8 million shares of common stock outstanding. The board of directors said the quarterly...

Costamare Inc. Announces 2013 Annual Meeting of Stockholders
Marketwire - Tue Sep 03, 3:01PM CDT
Costamare Inc. (the "Company") (NYSE: CMRE), an international owner and provider of containerships for charter, announced today that its Board of Directors has called an annual meeting of the stockholders to be held in Athens, Greece on Thursday, October 31, 2013.

Will DryShips, Inc. (DRYS) Beat Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 05, 4:50PM CDT
DryShips, Inc. is set to release its second-quarter 2013 results after the market closes on Aug 8, 2013.

Costamare Inc. Announces Pricing of its 7.625% Series B Preferred Stock
Business Wire - Tue Jul 30, 5:32PM CDT
Costamare Inc. (the "Company") (NYSE: CMRE) announced today that its offering of 2,000,000 shares of its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.0001 per share, liquidation preference $25.00 per share (the "Series B Preferred Stock"), was priced at $25.00 per share. The gross proceeds from the offering before the underwriting discount and other offering expenses are expected to be $50,000,000. The Company has also granted the underwriters a 30-day option to purchase up to an additional 300,000 shares of the Series B Preferred Stock. Dividends will be payable on the Series B Preferred Stock at a rate of 7.625% per annum of the stated liquidation preference. Following the offering, the Company intends to file an application to list the Series B Preferred Stock on the New York Stock Exchange.

Why Seaspan Is Poised to Keep Soaring
Brian Pacampara, The Motley Fool - Motley Fool - Thu Jul 25, 5:00PM CDT
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, containership operator Seaspan has earned a coveted five-star ranking . With that in mind, let's take a...

Costamare Inc. (CMRE) Stock Research Links

CMRE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 74

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 57

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
RepData's New Platform Redefines Market Research Game

Updated Category News Views 34

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 118

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 49

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth and Trends in Nuclear Medicine

Updated Category News Views 326

Nuclear Medicine Market Trends and Growth Projections Nuclear medicine is becoming an essential part of modern healthcare systems, offering significant diagnostic and therapeutic benefits. Recent industry analysis shows that the nuclear medicine market, valued at US$ 5.2 billion in 2022, is projected to grow to an astounding US$ 11.4 billion by 2031. This growth...

Continue Reading
Bitcoin Resilience: Experts Forecast Continued Growth Amid Dip

Updated Category News Views 107

Experts Forecast Bitcoin's Continued Growth In recent discussions, cryptocurrency experts have expressed a common belief that Bitcoin's long-term trajectory remains robust despite current fluctuations. Bitcoin has faced challenges in the short term, but the overarching consensus suggests that its bull market is far from over. The Impact of Federal Reserve Policies...

Continue Reading
Iovance Investors Urged to Act Before the July 14 Deadline

Updated Category News Views 170

Important Notice for Iovance Investors Levi & Korsinsky, LLP is reaching out to investors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) regarding a class action securities lawsuit. This notice serves to inform shareholders of the impending deadline for becoming a lead plaintiff, which is set for July 14, 2025. Class Action Overview The legal action aims to recover...

Continue Reading
Startek® South Africa Achieves Best Employer Brand Award

Updated Category News Views 256

Startek® South Africa Celebrates Employer Branding Success Startek®, a leader in global customer experience solutions, is making waves in the industry with its recent accolade at the South Africa Leadership Awards. Startek's South Africa operations received the prestigious Best Employer Brand Award for 2025, recognizing their exceptional approach to employee engagement...

Continue Reading
ESS Tech Launches Energy Center™ Product for Sustainable Energy

Updated Category News Views 220

ESS Tech Introduces Energy Center™ Product ESS Tech, Inc. (NYSE: GWH), a frontrunner in the field of long-duration energy storage systems, has proudly announced the commercial launch of its innovative Energy Center™ product. This milestone comes with the successful delivery of multiple systems to a prominent utility in Florida, along with the completion of...

Continue Reading